PlainRecalls

Clark Laboratories, Inc. (dba,Trinity Biotech USA)

Compiled from official public sources by the publisher.

9 recalls on record · Latest: Dec 26, 2018

Subscribe to new Clark Laboratories, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Clark Laboratories, Inc. LIGHT-BOOK · SINGLE-AGENCY

#1,581 of 14,151 · 9 notices · 0.009% archive

  • BOOK 9 notices
  • RANK #1,581 of 14,151
  • SHARE 0.009% archive
  • AGENCY FDA Devices (9)
  • CAT medical devices
  • CATS 1 category
  • LATEST Dec 26, 2018
  • PHOTO 3Cs Organics LLC

Nearest notice-volume peer: 3Cs Organics LLC (0 notice gap)

Clark Laboratories, Inc. (dba,Trinity Biotech USA) accounts for about 0.009% of the 104,423-notice archive on 9 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Clark Laboratories, Inc. sits among 14,151 recalling firms

Clark Laboratories, Inc. (dba,Trinity Biotech USA) ranks 1,581st of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Clark Laboratories, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

9 1581st of 14151 higher than 12,464 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Clark Laboratories, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Clark Laboratories, Inc. (dba,Trinity Biotech USA) holds about 0.009% of archive notices alongside 9 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Devices Moderate Dec 26, 2018

ultra2 Genesys Variants Analyzer, REF 03-01-0045 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.
FDA Devices Moderate Dec 26, 2018

Genesys 2 Reagent, REF 01-03-0022 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.
FDA Devices Moderate Dec 26, 2018

Genesys Analytical Column, REF 01-05-0017 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.
FDA Devices Moderate Dec 26, 2018

Genesys 1 Reagent, REF 01-03-0020 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.
FDA Devices Moderate Dec 26, 2018

Genesys Diluent Reagent, REF 01-03-0019 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.
FDA Devices Low Sep 21, 2016

Trinity Biotech Captia Measles IgM, REF/Product Code 2326060,Test Kit for 96 Determinations, IVD
FDA Devices Low Dec 24, 2014

Trinity biotech Captia (TM) Syphilis IgM Capture Test Kit, Product No./REF 800-935, Test Kit for 96 Determinations, IVD for In Vitro Diagnostic use; an antibody class capture enzyme immunoassay for the detection of IgM antibodies to T. pallidum as an aid to the identification of active syphilis in human serum.
FDA Devices Moderate Jan 1, 2014

Captia Syphilis-G Test Kit Product Usage: This is an enzyme immunoassay for the qualitative detection of IgG antibodies to T. pallidum in serum specimens, to be used in conjunction with non-treponemal testing to provide serological evidence of infection with T. pallidum ( the agent of syphilis). It is also intended for testing of serum or plasma specimens to screen blood and/or plasma donors to exclude a history of syphilis.
FDA Devices Low Oct 3, 2012

Trinity Biotech, Captia VZV IgG. Product code 2325600: 96 Tests; product code: 2325601: 480 tests. For in vitro diagnostic use. Intended for the detection and quantitative determination of IgG antibody to VZV in human sera.

Clark Laboratories, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Clark Laboratories, Inc.? ▼
PlainRecalls indexes 9 distinct federal recall events naming Clark Laboratories, Inc. (dba,Trinity Biotech USA), aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Clark Laboratories, Inc. sit among other recalling firms? ▼
Clark Laboratories, Inc. (dba,Trinity Biotech USA) ranks #1,581 of 14,151 by distinct recall-event count among 14,151 firms in this archive (88th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Clark Laboratories, Inc.'s notices? ▼
FDA Devices accounts for 9 of this firm's 9 indexed notices.
What product category dominates Clark Laboratories, Inc.'s filing book? ▼
Filings for Clark Laboratories, Inc. (dba,Trinity Biotech USA) span 1 product category, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Clark Laboratories, Inc. (dba,Trinity Biotech USA): 9 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Devices). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Clark Laboratories, Inc. (dba,Trinity Biotech USA); individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026